Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-27T12:59:24.207Z Has data issue: false hasContentIssue false

Effects of Cognitive Remediation in Patients with Mood Disorder

Published online by Cambridge University Press:  15 April 2020

Z. Abbes
Affiliation:
Child and Adolescent Psychiatry Department, Razi Hospital, Mannouba, Tunisia
H. Ben Yahia
Affiliation:
Child and Adolescent Psychiatry Department, Razi Hospital, Mannouba, Tunisia
M. Boudali
Affiliation:
Child and Adolescent Psychiatry Department, Razi Hospital, Mannouba, Tunisia
S. Halayem
Affiliation:
Child and Adolescent Psychiatry Department, Razi Hospital, Mannouba, Tunisia
S. Othman
Affiliation:
Child and Adolescent Psychiatry Department, Razi Hospital, Mannouba, Tunisia
A. Bouden
Affiliation:
Child and Adolescent Psychiatry Department, Razi Hospital, Mannouba, Tunisia
S. Ouanes
Affiliation:
Psychiatry E Department, Razi Hospital, Manouba, Tunisia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Neurocognitive impairment constitutes a core feature of mood illness. It compromises personal and social functioning. Cognitive Remediation (CR) is accepted as an important therapeutic intervention in schizophrenia, but few studies provide data on whether the benefits extend to mood disorder.

Objectives

To examine the profile and magnitude of cognitive impairments in mood disorder, review the evidence in support of CR for this population, and discuss future research directions in CR.

Methods

A literature search was conducted using Medline database. Combinations of multiple keywords were searched: mood disorder, neurocognition, cognitive remediation, cognitive training, functional remediation. Randomized-controlled trials and key studies published until 2013 were included.

Results

We included seven studies, comprising a total of 398 participants, 71% of whom had bipolar disorder, 14% schizophrenia, 12% major depressive disorder, and 3% schizoaffective disorder. Only two studies included merely patients with bipolar disorder. It has been estimated that 30 to 60% of patients with bipolar disorder have trait-related cognitive deficits. In two studies, patients received a non-computerized programme. In the five other studies, a computer-assisted programme was delivered. The average duration of therapy was about 13.1 weeks. Effect sizes ranged from 0.33 to 0.93. Results showed that improvements in executive functioning were associated with improvements in occupational functioning.

Conclusion

CR in patients with mood disorder may be an effective non-pharmacological treatment option for improving cognitive functions, which may improve psychosocial functioning. Further studies are required to examine the durability of any gains with CR in these patients.

Type
Article: 1659
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.